Choong Ang Vaccine Laboratory Co (072020) Fair Value & Analysis
Healthcare · KR · Market cap 91.3B KRW
Fair value as of: Jun 24, 2026
Analysis
Choong Ang Vaccine Laboratory Co (072020) currently trades at 9,200 KRW, while our model-based Fair Value estimate is 7,741 KRW — implying the stock looks roughly 15.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Choong Ang Vaccine Laboratory Co (072020) undervalued?
What is the fair value of 072020?
What is the quality score of 072020?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.